ARCHIVES

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Northwestern’s Warren Kibbe Named Director of NCI CBIIT

June 26, 2013

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

February 15, 2002

FDA Designates Zometa For Priority Review.

November 30, 2001

Zubrod To Retire as Miami Director; Baker Succeeds Brennan As Director Of Detroit Center

January 29, 1988

Biostatisticians Write To Varmus Asking NCI To Investigate

July 23, 2010

Shingleton To Retire As Director Of Duke Comprehensive Center

July 10, 1981